Immune responses limit adenovirally mediated gene expression in the adult mouse eye

Gene Therapy

Volumn 5, Issue 8, 1998, Pages 1038-1046

  Reichel, M B ^a   Ali, R R ^a   Thrasher, A J ^b   Hunt, D M ^a   Bhattacharya, S S ^a   Baker, D ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Adenovirus; Eye; Immune privilege; Immune response

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTERIOR EYE CHAMBER; ARTICLE; CONJUNCTIVA; EYE; GENE EXPRESSION REGULATION; GENE TRANSFER; IMMUNE RESPONSE; IMMUNOCOMPETENCE; IMMUNOSUPPRESSIVE TREATMENT; MOUSE; NONHUMAN; PRIORITY JOURNAL; RETINA; T LYMPHOCYTE; TARGET ORGAN;

ADENOVIRIDAE; ANIMALIA; DNA VIRUSES; MUS MUSCULUS;

EID: 0031687272     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3300691     Document Type: Article

References (37)

1. Ali RR et al. Adeno-associated virus gene transfer to mouse retina. Hum Gene Ther 1998; 9: 81-86.
2. Jomary C et al. Rescue of photoreceptor function by AAV-mediated gene transfer in a mouse model of inherited retinal degeneration. Gem Therapy 1997; 4: 683-690.
3. Zolotukhin S et al. A 'humanized' green fluorescent protein cDNA adapted for high-level expression in mammalian cells. J Virol 1996; 70: 4646-4654.
4. Ali RR et al. Gene transfer into the mouse retina mediated by an adeno-associated viral vector. Hum Mol Genet 1996; 5: 591-594.
5. Pepose JS, Leib DA. Herpes simplex viral vectors for therapeutic gene delivery to ocular tissues - recent breakthroughs in the molecular genetics of ocular diseases. Invest Ophthalmol Vis Sci 1994; 35: 2662-2666.
6. Hangai M, Kaneda Y, Tanihara H, Honda Y. In vivo gene transfer into the retina mediated by a novel liposome system. Invest Ophthalmol Vis Sci 1996; 37: 2678-2685.
7. Hoffman LM, Maguire AM, Bennett J. Cell-mediated immune response and stability of intra-ocular transgene expression after adenovirus-mediated delivery. Invest Ophthalmol Vis Sci 1997; 38: 2224-2233.
8. Cayouette M, Gravel C. Adenovirus-mediated gene transfer of ciliary neurotrophic factor can prevent photoreceptor degeneration in the retinal degeneration (rd) mouse. Hum Gene Ther 1997; 8: 423-130.
9. Bennett J et al. Photoreceptor cell rescue in retinal degeneration (rd) mice by in vivo gene therapy. Nature Med 1996; 2: 649-654.
10. Borras T, Tamm ER, Zigler JSJ. Ocular adenovirus gene transfer varies in efficiency and inflammatory response. Invest Ophthal Vis Sci 1996; 37: 1282-1293.
11. Abraham NG et al. Adenovirus-mediated heme oxygenase-1 gene transfer into rabbit occular tissues. Invest Ophthalmol Vis Sci 1995; 36: 2202-2210.
12. Budenz DL, Bennett J, Alonso L, Maguire A. In vivo gene transfer into murine corneal endothelial and trabecular meshwork cells. Invest Opthalmol Vis Sci 1995; 36: 2211-2215.
13. Bennett J et al. Adenovirus vector-mediated in vivo gene transfer into adult murine retina. Invest Ophthalmol Vis Sci 1994; 35: 2535-2542.
14. Li T et al. In vivo transfer of a reporter gene to the retina mediated by an adenoviral vector. Invest Ophthalmol Vis Sci 1994; 35: 2543-2549.
15. Mashhour B, Couton D, Perricaudet M, Briand P. In vivo adenovirus mediated gene transfer into ocular tissues. Gene Therapy 1994; 1: 112-126.
16. Jomary C et al. Adeno-virus mediated gene transfer to murine retinal cells in vitro and in vivo. FEBS Lett 1994; 347: 117-122.
17. Ali RR, Reichel MB, Hunt DM, Bhattacharya SS. Gene therapy for inherited retinal disease. Br J Ophthalmol 1997; 81: 795-801.
18. Kass-Eisler A et al. The impact of developmental stage, route of administration and the immune system on adenovirus-mediated gene transfer. Gene Therapy 1994; 1: 395-402.
19. Dai Y et al. Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression. Proc Natl Acad Sci USA 1995; 92: 1401-1405.
20. Yang Y, Haecker SE, Su Q, Wilson JM. Immunology of gene therapy with adenoviral vectors in mouse skeletal muscle. Hum Mol Genet 1996; 5: 1713-1726.
21. Barr D et al Strain-related variations in adenovirally mediated transgene expression from mouse hepatocytes in vivo-, comparisons between immunocompetent and immunedeficient strains. Gene Therapy 1995; 2: 151-155.
22. Yang Y, Xiang Z, Ertl HCJ, Wilson JM. Upregulation of class I MHC antigens by interferon-γ is necessary for the T cell-mediated elimination of recombinant adenovirus infected hepatocytes in vivo. Proc Natl Acad Sci USA 1995; 92: 7257-7261.
23. Yang Y, Trinchieri G, Wilson JM. Recombinant IL-12 prevents formation of blocking IgA antibodies to recombinant adenovirus and allows repeated gene therapy to mouse lung. Nature Med 1995; 1: 890-893.
24. DeMatteo RP et al. Prolongation of adenoviral transgene expression in mouse liver by T lymphocyte subset depletion. Gene Therapy 1996; 3: 4-12.
25. Niederkorn JY. Immune privilege and immune regulation in the eye. Adv Immunol 1990; 48: 191-226.
26. Jiang LQ, Streilein JW. Subretinal space and vitreous cavity as immunologically privileged sites for retinal allografts. Invest Ophthalmol Vis Sci 1993; 34: 3347-3354.
27. Jiang LQ, Streilein JW, McKinnek C. Immune privilege in the eye: an evolutionary adaptation. Dev Comp Immunol 1994; 18: 421-431.
28. O'Neill JK et al. Control of immune-mediated disease of the central nervous system with monoclonal (CD4-specific) antibodies. J Neuroimmunol 1993; 45: 1-14.
29. Oral HB et al. Ex vivo adenovirus-mediated gene transfer and immunomodulatory protein production in human cornea. Gene Therapy 1997; 4: 639-647.
30. Cobbold SP, Martin G, Qin S, Waldmann H. Monoclonal antibodies to promote marrow engraftment and tissue graft tolerance. Nature 1996; 323: 164-166.
31. Wekerle H, Linington C, Lassman H, Mayermann R. Cellular immune reactivity within the CNS. Trends Neurosci 1986; 9: 271-277.
32. Byrnes AP, MacLaren RE, Charlten HM. Immunological instability of persistent adenovirus vectors in the brain: peripheral exposure to vector leads to renewed inflammation, reduced gene expression and demvelination. J Neurosci 1996; 16: 3045-3055.
33. Bennett J, Pakola S, Zeng Y, Maguire A. Humoral response after administration of E1-deleted adenoviruses: immune privilege of the subretmal space. Hum Gene Ther 1996; 7: 1763-1769.
34. Hoffman LM, Maguire A, Bennett J. Cell-mediated immune response and stability of intra-ocular transgene expression after adenovirus-mediated delivery. Invest Ophthalmol Vis Sci 1997; 38: (Abstr. 4421).
35. Byrnes AP, Rusby JE, Wood MJA, Charlton HM. Adenovirus gene transfer causes inflammation in the brain. Neuroscience 1995; 66: 1015-1024.
36. Graham FL, Prevec L. Manipulation of adenovirus vectors. In. Murray EJ (ed). Methods in Molecular Biology, vol 7. Humana Press: Clifton, NJ, 1991, pp 109-128.
37. Baker D et al. Induction of chronic relapsing experimental allergic encephalomyelitis in Biozzi mice. J Neuroimmunol 1990; 28: 261-270.